The Tandem Basal-IQ predictive low glucose suspend (PLGS) system has recently been approved by the FDA for pump users as young as six years old. It is a feature of the newest Tandem t:slim X2 insulin pumps (and available as a software update for older t:slim X2 pumps), working in collaboration with the Dexcom G6 continuous glucose monitoring system (CGM). The new PLGS algorithm stops basal insulin delivery when low blood sugar is predicted (30 minutes ahead of time), suspends, and then restarts insulin delivery once blood sugar levels begin to rise. The goal is to prevent or reduce hypoglycemia (low blood sugar) in users, without alarms.
The American Diabetes Association defines hypoglycemia: “Low blood glucose (hypoglycemia) is when your blood glucose levels have fallen low enough that you need to take action to bring them back to your target range. This is usually when your blood glucose is less than 70 mg/dL.” Study results have shown that the Tandem Basal-IQ predictive low glucose suspend system reduced time in hypoglycemia by 31%, or about 19 minutes per day. The Basal-IQ system is also the first automated insulin delivery system compatible with a no-fingerstick calibration CGM (the Dexcom G6).
All of the Tandem t:slim X2 pumps shipping from Healthy Living Medical Supply now have the updated Basal-IQ PLGS algorithm. If you already have a Tandem t:slim X2 pump and it’s in warranty, you will be able to get a software update to obtain the new algorithm. The Basal-IQ Technology software update for the t:slim X2 Insulin Pump is now available – get started here. The collective capabilities of insulin pumps and CGM keep wowing us! To find out more about new ways like this to help manage diabetes, call our Insulin Pump & CGM Therapy team at 866.779.8512 (option 2). We are here to help!
